These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26064856)

  • 21. Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.
    Tsuchiya N; Sato K; Akao T; Kakinuma H; Sasaki R; Shimoda N; Satoh S; Habuchi T; Ogawa O; Kato T
    Tohoku J Exp Med; 2001 Oct; 195(2):101-13. PubMed ID: 11846206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.
    Wang X; Liu Y; Cao G; Zhang X; Xu H; Xu H; Wang J
    Int J Clin Exp Pathol; 2015; 8(6):6821-7. PubMed ID: 26261568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Nuclear Morphometry and Ki-67 Index in Clear Cell Renal Cell Carcinomas: a Five-Year Study.
    Sheela Devi CS; Suchitha S; Veerendrasagar RS
    Iran J Pathol; 2017; 12(2):150-157. PubMed ID: 29515637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Low expressions of EHD2 and E-cadherin correlate with a poor prognosis for clear cell renal cell carcinoma].
    Ye M; Fan G; Zhu S; Han W; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 44(8):864-870. PubMed ID: 31570672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
    Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
    Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
    Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
    Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
    Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 expression and its prognostic significance in clear cell renal cell carcinoma.
    Lee JW; Park JH; Suh JH; Nam KH; Choe JY; Jung HY; Chae JY; Moon KC
    Korean J Pathol; 2012 Jun; 46(3):237-45. PubMed ID: 23110009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
    Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
    J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
    Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
    Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma.
    Capp C; Wajner SM; Siqueira DR; Brasil BA; Meurer L; Maia AL
    Thyroid; 2010 Aug; 20(8):863-71. PubMed ID: 20615131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GRIM-19 deficiency promotes clear cell renal cell carcinoma progression and is associated with high TNM stage and Fuhrman grade.
    Yan N; Feng X; Jiang S; Sun W; Sun MZ; Liu S
    Oncol Lett; 2020 Jun; 19(6):4115-4121. PubMed ID: 32382350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases.
    Nishikimi T; Tsuzuki T; Fujita T; Sassa N; Fukatsu A; Katsuno S; Yoshino Y; Hattori R; Gotoh M
    Pathol Int; 2011 Mar; 61(3):116-21. PubMed ID: 21355952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor.
    Sacré A; Barthélémy P; Korenbaum C; Burgy M; Wolter P; Dumez H; Lerut E; Loyson T; Joniau S; Oyen R; Debruyne PR; Schöffski P; Beuselinck B
    Acta Oncol; 2016; 55(3):329-40. PubMed ID: 26494607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.